Initial clinical experience with the modified Zenith "Pro-Form" TX2 thoracic endograft

Germano Melissano, Efrem Civilini, Luca Bertoglio, Davide Logaldo, Roberto Chiesa

Research output: Contribution to journalArticlepeer-review


Purpose: To assess the safety and efficacy of thoracic aortic endovascular repair (TEVAR) with the newly introduced Zenith TX2 thoracic stent-graft with Pro-Form. Methods: From March 2009 to present, the Zenith TX2 with Pro-Form was used to treat 27 patients (23 men; median age 65 years, range 22-77) suffering from descending thoracic aortic disease: 20 degenerative aneurysms, 3 chronic type B dissections, 2 type I endoleaks following previous endograft repair, 1 aortic ulcer, and 1 traumatic isthmic rupture. According to Ishimaru's classification, the distribution of the proximal landing zone was zone 0 in 4 cases, zone 1 in 2 cases, zone 2 in 9 cases, zone 3 in 7 cases, and zone 4 in 5 cases. One aneurysm distally involved the thoracoabdominal aorta. An acutely angulated (

Original languageEnglish
Pages (from-to)463-470
Number of pages8
JournalJournal of Endovascular Therapy
Issue number4
Publication statusPublished - Aug 2010


  • Thoracic aortic aneurysm
  • Thoracic aortic dissection
  • Thoracic endovascular aortic repair
  • Thoracic stent-graft

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Radiology Nuclear Medicine and imaging


Dive into the research topics of 'Initial clinical experience with the modified Zenith "Pro-Form" TX2 thoracic endograft'. Together they form a unique fingerprint.

Cite this